These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Correlation Between Impaired Sensitivity to Thyroid Hormones and Serum Uric Acid in Female Patients With Obesity and After Laparoscopic Sleeve Gastrectomy. Wen X, You H, Wei L, Guo J, Su L, Wang L, Zhang M, Sun H, Chen H, Bu L, Qu S. Endocr Pract; 2024 May; 30(5):417-423. PubMed ID: 38479647 [Abstract] [Full Text] [Related]
31. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Liu PJ, Ma F, Lou HP, Zhu YN, Chen Y. Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478 [Abstract] [Full Text] [Related]
32. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity. Medrano M, Arenaza L, Migueles JH, Rodríguez-Vigil B, Ruiz JR, Labayen I. Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015 [Abstract] [Full Text] [Related]
33. The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease. Batman B, Altun H, Simsek B, Aslan E, Namli Koc S. Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):509-512. PubMed ID: 31107849 [Abstract] [Full Text] [Related]
34. Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats. Méndez-Giménez L, Becerril S, Moncada R, Valentí V, Ramírez B, Lancha A, Gurbindo J, Balaguer I, Cienfuegos JA, Catalán V, Fernández S, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Obes Surg; 2015 Sep; 25(9):1723-34. PubMed ID: 25736229 [Abstract] [Full Text] [Related]
36. Short-term changes and correlations of plasma spexin, kisspeptin, and galanin levels after laparoscopic sleeve gastrectomy. Atabey M, Aykota MR, Özel Mİ, Arslan G. Surg Today; 2021 Apr; 51(4):651-658. PubMed ID: 33555434 [Abstract] [Full Text] [Related]
37. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound. Petrović G, Bjelaković G, Benedeto-Stojanov D, Nagorni A, Brzački V, Marković-Živković B. Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896 [Abstract] [Full Text] [Related]
39. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease. Wasilewska N, Bobrus-Chociej A, Harasim-Symbor E, Tarasów E, Wojtkowska M, Chabowski A, Lebensztejn DM. Lipids Health Dis; 2018 Sep 12; 17(1):216. PubMed ID: 30208901 [Abstract] [Full Text] [Related]